Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.

Area of Science:

• Biochemistry and Molecular Biology
• Nephrology
• Genetics

Background:

• MicroRNAs (miRNAs) are key post-transcriptional regulators implicated in diabetic nephropathy (DN) pathogenesis.
• Urinary exosomal miRNAs are stable and reflect renal status, making them promising biomarkers.

Purpose of the Study:

• To profile urinary exosomal miRNAs in healthy controls, type II diabetes (T2D) patients, and T2D with nephropathy (DN) patients.
• To identify specific miRNAs associated with DN and its progression.

Main Methods:

• Urinary exosomal miRNA profiling using Agilent's miRNA microarrays in 8 controls, 8 T2D, and 8 DN patients.
• Validation of key miRNA expression using qRT-PCR.
• Correlation analysis with micro-albuminuria levels.

Main Results:

• 16 miRNA species showed significant deregulation (>2-fold) in DN patients compared to controls and T2D patients.
• 14 miRNAs were upregulated, and 2 were downregulated in DN patients.
• Deregulation was observed in micro-albuminuric DN patients, with miR-320c and miR-6068 showing strong upregulation and correlation with micro-albuminuria.

Conclusions:

• Urinary exosomal miRNA profiles are altered in type II diabetic nephropathy.
• Deregulated miR-320c, potentially targeting the TGF-β pathway via TSP-1, is a promising candidate biomarker for monitoring DN progression.